Skip to main content
Smitha Krishnamurthi, MD, Hematology, Cleveland, OH, University Hospitals Cleveland Medical Center

SmithaSKrishnamurthiMD

Hematology Cleveland, OH

Assistant Professor, Medicine, Case Western Reserve University School of Medicine

Dr. Krishnamurthi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Krishnamurthi's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1993 - 1996
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1993

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2000 - 2024
  • MD State Medical License
    MD State Medical License 1996 - 2001
  • PA State Medical License
    PA State Medical License 1994 - 1996

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2012-2014
  • America's Top Doctors for Cancer Castle Connolly, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Local Man Shares Colorectal Cancer Story as Diagnosis Increasing in Adults Younger Than 50
    Local Man Shares Colorectal Cancer Story as Diagnosis Increasing in Adults Younger Than 50March 15th, 2021
  • New Immunotherapy Agent Reduces Disease Progression Risk in Gastric Cancers
    New Immunotherapy Agent Reduces Disease Progression Risk in Gastric CancersJune 14th, 2016
  • Capecitabine Combo Improves Survival in Resected Pancreatic Cancer
    Capecitabine Combo Improves Survival in Resected Pancreatic CancerJune 3rd, 2016
  • Join now to see all

Grant Support

  • Erlotinib And Modified FOLFOX6 In Patients With Metastatic Colorectal CancerNational Center For Research Resources2006

Hospital Affiliations